Coral Laboratories P/B Ratio
Coral Laboratories (CORALAB) P/B ratio is 0.76 (Low), book value per share ₹502.50 vs Healthcare average P/B of -0.93 — Low - Trading below book value, may indicate undervaluation. For live price, earnings yield and the full fundamental profile, see CORALAB stock price BSE.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
CORALAB P/B Ratio — Valuation Insights & Book Value Analysis
Coral Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 0.76 (Low). View CORALAB 52-week chart for the annual high/low range and current price position.
- Stock appears undervalued with PB of 0.76, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 30.1% below historical average
- Trading at premium to sector average PB of -0.93
Coral Laboratories P/B Ratio Historical Trend
CORALAB annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with CORALAB fair value to assess whether the stock is under or overvalued.
CORALAB Historical P/B Ratio — Book Value Per Share & Year-End Price
Coral Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.87 | ₹502.5 | ₹438.50 | ₹201 | Low |
| 2024 | 1.71 | ₹445.0 | ₹762.85 | ₹178 | Moderate |
| 2023 | 1.12 | ₹387.5 | ₹435.15 | ₹155 | Moderate |
| 2022 | 0.83 | ₹390.0 | ₹322.30 | ₹156 | Low |
| 2021 | 0.91 | ₹342.5 | ₹311.25 | ₹137 | Low |
CORALAB vs Healthcare Peers — P/B Ratio Comparison
Coral Laboratories P/B 0.76 vs Healthcare average -0.93, median 0.6 — range -31.21–1.04.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |